A Brain Research Meeting

REGISTER NOW!

Complete the online form

Join mailing list

Add this event to your calendar

View invited speakers

Program

Brain Research

Tell your Colleagues about this Event

Email Alerts...

Downloads

Program • Poster program

Thursday November 11
8.15	Welcome and Introduction Joseph Buxbaum
Session 1 - Genetics and genomics of Autism spectrum disorders Chair: J. Buxbaum, Mount Sinai School of Medicine, USA
8.30	O1- Autism spectrum disorders: behavioral manifestations of numerous genetic disorders C. Betancur, INSERM U952, Université Pierre et Marie Curie, France
9.00	O2- The genomic architecture in Autism spectrum disorder S. Scherer, The Hospital for Sick Children, The university of Toronto, Canada
9.30	O3- TBC B. Devlin, UPMC, USA
10.00	O4- Next-generation sequencing in autism spectrum disorders J. Buxbaum, Mount Sinai School of Medicine, USA
10.30	Coffee Break
Session 2: Animal models of Autism spectrum disorders Chair: J. Crawley, NIMH, USA
11.00	O5- Behavioral phenotyping strategies for genetic mouse models of Autism J. Crawley, NIMH, USA
11.30	O6- *Using a Drosophila* model to investigate the underlying causes of symptoms associated with fragile X syndrome** T. Jongens, University of Pennsylvannia, USA
12.00	O7- Haploinsufficiency of Shank3 leads to neuronal deficits in a mouse model of Phelan-McDermid syndrome J. Buxbaum, Mount Sinai School of Medicine, USA
12.30	O8- Adult reversal of neurodevelopmental disorders: Impact on autism A. Silva, University of California at Los Angeles, USA
1.00	Lunch
Session 3: Changes in brain growth and function from infancy to adulthood in Autism Chair: E. Courchesne, University of California at San Diego, USA
2.00	O9- Structural defects that underlie autism: Overgrowth in the first years of life followed by arrest and degeneration E. Courchesne, University of California at San Diego, USA
2.30	O10- Early Neurofunctional Signatures of Autism between 12 and 36 months K. Pierce, University of California at San Diego, USA
3.00	O11- The neurobiology of Autism in adulthood D. Murphy, Institute of Psychiatry, Kings College London, UK
3.30	Coffee Break
Session 4: Research into the neuropathology of Autism Chair: D. Amaral, University of California at Davis, USA
4.00	O12- Atypical cytoarchitecture in the amygdala and temporal cortex in autism C. Schumann, University of California at Davis, USA
4.30	O13- Regionally discrete and cell type-specific neocortical neuronal pathology in autism P. Hof, Mount Sinai School of Medicine, USA
5.00	O14- Alterations in the GABAergic system in the Autism brain: Emerging evidence for widespread defects in cerebellar, limbic and cortical regions G. Blatt, Boston University School of Medicine, USA
5.30	O15- Molecular neuropathology in ASD: clues in pathogenesis C. Pardo, Johns Hopkins University School of Medicine, USA
6.00	Poster reception
Friday November 12
Session 5: Understanding the behaviors in ASD that brain approaches are attempting to explain Chair: C. Lord, University of Michigan Autism and Communication Disorders Center, USA
9.00	O16- Does understanding the cognitive phenotype help us in understanding the behavioral phenotype of autism? T. Charman, Institute of Education, University of London, UK
9.30	O17- Beyond recognition: face processing abnormalities in young children with ASD K. Chawarska, Yale University, USA
10.00	O18- Trajectories and dimensions in behavioral features of ASD C. Lord, University of Michigan Autism and Communication Disorders Center, USA
10.30	Coffee Break
Session 6: Cutting edge research in behavioral interventions for ASD Chair: S. Rogers, University of California Davis Medical Center
11.00	O19- Parent-assisted children’ friendship training for children with high functioning Autism spectrum disorders F. Frankel, University of California at Los Angeles, USA
11.30	O20- Towards a technology of treatment individualization for young children with Autism A. Stahmer, The Child and Adolescent Services Research Center , USA
12.00	O21- Group cognitive behavior therapy for children and adolescents with high-functioning Autism spectrum disorders and anxiety J. Reaven, University of Colorado School of Medicine, USA
12.30	O22- Developing treatments for infants and toddlers with autism S. Rogers, University of California Davis Medical Center
1.00	Lunch
Session 7: Pharmacological interventions for Autism spectrum disorders Chair: C. McDougle, Indiana University School of Medicine, USA
2.00	O23- Pharmacotherapy of irritability in Autism spectrum disorders C. McDougle, Indiana University School of Medicine, USA
2.30	O24- Pharmacotherapy of hyperactivity and repetitive behaviors in autism spectrum disorders B. King, University of Washington, USA
3.00	O25- Developing drugs for core social and communication impairment in Autism C. Erickson, MD, Indiana University School of Medicine , USA
3.30	Coffee Break
Session 8: Plenary session
4.00	PLENARY PRESENTATION D. Amaral, University of California at Davis, USA
4.45	Closing remarks

Downloads

Thursday November 11

Friday November 12